Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates
Summary
GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates". An essential source of information and analysis on the Polish healthcare, regulatory and reimbursement landscape, this report identifies the key trends in the healthcare market, as well as providing insights on the demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts. In 2011, the UAE population was 8.4 million which was mainly due to the increasing number of immigration in the country. In 2011, the pharmaceutical market was estimated at $1.9 billion and is expected to reach $3.7 billion by 2020 at a projected CAGR of 7%. The medical device market was worth approximately $670.7m in 2011 and is expected to reach $979m by 2020 at a projected CAGR of 4%.
The positive trends in United Arab Emirates healthcare market can be attributed primarily to -
Multiple health-care facilities
Liberal trade policies
Medical tourism
Scope
An overview of the pharmaceutical and medical device markets, including size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical and medical device markets. The key players covered for the pharmaceutical market are Julphar, Neopharma, GlaxoSmithKline, Pfizer, and Novartis, and the key players covered for the medical device market are F. Hoffmann-La Roche Ltd, Siemens Healthcare, Medtronic, Boston Scientific Corporation Inc and Abbott Laboratories.
Insightful review of the reimbursement and regulatory landscape, with details of the reimbursement process, regulatory agencies and market authorization processes for new drug and medical devices
Detailed analysis of United Arab Emirates political and economic environment, including economic indicators, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy
Develop business strategies by understanding the trends shaping and driving the healthcare market in United Arab Emirates.
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical and medical devices market segments and companies likely to impact the healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors.
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnerships
Identify, understand and capitalize on the opportunities and challenges in the healthcare market
Table of Contents
TOC
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 Report Guidance 10
3 Overview of the Pharmaceutical and Medical Device Markets 11
3.1 Pharmaceutical Market 11
3.1.1 Market Overview 11
3.1.2 Supply Channels 13
3.1.3 Market Segments 15
3.1.4 Over-the-Counter Drugs 17
3.1.5 Major Therapeutic Areas 18
3.1.6 Major Players 21
3.2 Medical Device Market 45
3.2.1 Market Overview 45
3.2.2 Overview of the Top Five Segments 48
3.2.3 Major Players 59
3.3 Market Drivers and Barriers 79
3.3.1 Drivers 79
3.3.2 Barriers 80
4 Market Access 82
4.1 Reimbursement and Payer Landscape 82
4.1.1 Healthcare System Overview 82
4.1.2 Reimbursement Process 82
4.1.3 Overview of Insurance Providers 85
4.1.4 Patient Share in Healthcare Spending 86
4.1.5 Price Trends in Healthcare Services 88
4.1.6 Pricing Policies 89
4.2 Regulatory Landscape 90
4.2.1 Overview of Regulatory Agencies 90
4.2.2 New Drug Approval Process 93
4.2.3 Marketing Authorization Procedure for Generic Pharmaceutical Products 94
4.2.4 Medical Device Approval Process 96
4.2.5 Licensing Process for Pharmaceutical and Medical Device Manufacturing 97
4.2.6 Licensing Process for Pharmaceutical Exports and Imports 98
4.2.7 Intellectual Property Rights 98
4.2.8 Clinical Trial Regulations 103
4.2.9 Pharmaceutical Advertising Regulations 105
4.2.10 Pharmacy Regulations 105
4.2.11 Labeling and Packaging Regulations 106
5 Country Analysis 108
5.1 Political Environment 108
5.1.1 Political Structure 108
5.1.2 Analysis of the Current Political Environment 109
5.1.3 Healthcare Policy Initiatives 110
5.2 Economic Landscape 111
5.3 Economic Indicators 113
5.3.1 Gross Domestic Product 113
5.3.2 Gross National Income 118
5.3.3 Inflation 119
5.3.4 Currency Exchange Rate 123
5.3.5 Foreign Direct Investment 124
5.3.6 Foreign Exchange Reserves 125
5.3.7 Trade Balance 126
5.3.8 Government Net Debt 128
5.3.9 Major Industries 130
5.4 Demography 131
5.4.1 Population 131
5.4.2 Education and Literacy 148
5.4.3 Employment 150
5.4.4 Disease Burden 152
5.5 Healthcare Infrastructure 154
5.5.1 Healthcare Facilities 154
5.5.2 Healthcare Parameters 162
5.5.3 Environmental Health 164
5.5.4 Healthcare Personnel 167
5.6 Healthcare Expenditure 170
5.6.1 Overview 170
5.6.2 Major Components of Healthcare Spending 171
5.6.3 Share of Public and Private Sectors 172
5.7 Trade Associations 173
5.7.1 Arab Union of Producers of Drugs and Medical Supplies 173
5.7.2 Emirates Medical Association 173
5.7.3 Pharmaceutical Research and Manufacturers Association Gulf 173
5.7.4 Gulf Pharmaceutical Industries Association 173
5.7.5 Middle East Medical Devices and Diagnostics Trade Association 173
Figure 84: Opportunities and Challenges, Healthcare Market, UAE, 2012 177
Healthcare, Regulatory and Reimbursement Landscape - United Arab Emirates published by GlobalData in November 20, 2012. This report consists of Pages: 187 and the price starts from US $ 1995.
The contents of this page may be different from the latest version. Please contact us for details.
